Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Klein

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
The Lancet. HIV|March 19, 2022
Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort studyJennifer S Lee, Elizabeth Humes, Brenna C Hogan, et al.
Cannabis and Cannabinoid Research|October 4, 2019
Cannabis Consumption in People Living with HIV: Reasons for Use, Secondary Effects, and Opportunities for Health EducationCecilia T Costiniuk, Zahra Saneei, Syim Salahuddin, et al.
BMJ Open|January 18, 2022
Camu Camu effects on microbial translocation and systemic immune activation in ART-treated people living with HIV: protocol of the single-arm non-randomised Camu Camu prebiotic pilot study (CIHR/CTN PT032)Stéphane Isnard, Brandon Fombuena, Jing Ouyang, et al.
BMC Infectious Diseases|October 23, 2016
Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohortZachary Tanner, Nathan Lachowsky, Erin Ding, et al.
BMJ Open|January 23, 2023
Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO studyLéna Royston, Stéphane Isnard, Carolina A Berini, et al.
Canadian Liver Journal|July 28, 2023
Public reimbursement policies in Canada for direct-acting antiviral treatment of hepatitis C virus infection: A descriptive studyGaelen Snell, Alison D Marshall, Jennifer van Gennip, et al.
Canadian Journal of Gastroenterology & Hepatology|October 15, 2014
The 3rd Canadian Symposium on Hepatitis C Virus: expanding care in the interferon-free eraSonya A MacParland, Marc Bilodeau, Jason Grebely, et al.
Medicine|November 21, 2020
Impact of previous HIV resistance and virologic failures on virologic outcome following a switch to dolutegravir with 2 NRTIs among people living with HIVMohamed N'dongo Sangaré, Jean-Guy Baril, Alexandra de Pokomandy, et al.
BMC Infectious Diseases|November 23, 2019
Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada?Urvi Rana, Matt Driedger, Paul Sereda, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|November 7, 2022
Clinical and demographic predictors of antiretroviral efficacy in HIV-HBV co-infected patientsUrvi Rana, Matt Driedger, Paul Sereda, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
The Lancet. HIV|March 19, 2022
Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort studyJennifer S Lee, Elizabeth Humes, Brenna C Hogan, et al.
Cannabis and Cannabinoid Research|October 4, 2019
Cannabis Consumption in People Living with HIV: Reasons for Use, Secondary Effects, and Opportunities for Health EducationCecilia T Costiniuk, Zahra Saneei, Syim Salahuddin, et al.
BMJ Open|January 18, 2022
Camu Camu effects on microbial translocation and systemic immune activation in ART-treated people living with HIV: protocol of the single-arm non-randomised Camu Camu prebiotic pilot study (CIHR/CTN PT032)Stéphane Isnard, Brandon Fombuena, Jing Ouyang, et al.
BMC Infectious Diseases|October 23, 2016
Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohortZachary Tanner, Nathan Lachowsky, Erin Ding, et al.
BMJ Open|January 23, 2023
Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO studyLéna Royston, Stéphane Isnard, Carolina A Berini, et al.
Canadian Liver Journal|July 28, 2023
Public reimbursement policies in Canada for direct-acting antiviral treatment of hepatitis C virus infection: A descriptive studyGaelen Snell, Alison D Marshall, Jennifer van Gennip, et al.
Canadian Journal of Gastroenterology & Hepatology|October 15, 2014
The 3rd Canadian Symposium on Hepatitis C Virus: expanding care in the interferon-free eraSonya A MacParland, Marc Bilodeau, Jason Grebely, et al.
Medicine|November 21, 2020
Impact of previous HIV resistance and virologic failures on virologic outcome following a switch to dolutegravir with 2 NRTIs among people living with HIVMohamed N'dongo Sangaré, Jean-Guy Baril, Alexandra de Pokomandy, et al.
BMC Infectious Diseases|November 23, 2019
Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada?Urvi Rana, Matt Driedger, Paul Sereda, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|November 7, 2022
Clinical and demographic predictors of antiretroviral efficacy in HIV-HBV co-infected patientsUrvi Rana, Matt Driedger, Paul Sereda, et al.
Pageof 8